Vanda Pharmaceuticals Inc. is a company in the U.S. stock market and it is a holding in 64 U.S.-traded ETFs. VNDA has around 10.8M shares in the U.S. ETF market. The largest ETF holder of VNDA is the iShares Core S&P Small-Cap ETF (IJR), with approximately 3.34M shares. Investors may also find of interest that the ETF with the largest allocation to VNDA stock is Virtus LifeSci Biotech Products ETF (BBP), with a portfolio weight of 2.71%. On average, U.S. ETFs allocate 0.29% of VNDA to their portfolios.
Additionally, VNDA is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with VNDA as a holding is the ProShares UltraPro Russell2000 (URTY), with a return of 29.79%.